Related Experiment Video

Updated: Jul 6, 2026

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
09:37

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Published on: August 15, 2019

Genotype-phenotype correlation in children with familial Mediterranean fever in a Turkish population

Ruhan Duşunsel1, Ismail Dursun, Zübeyde Gündüz

  • 1Department of Pediatric Nephrology and Rheumatology, Erciyes University Faculty of Medicine, Kayseri, Turkey.

Pediatrics International : Official Journal of the Japan Pediatric Society
|March 21, 2008
PubMed
Abstract

Insights

Homozygosity for the M694V mutation in familial Mediterranean fever (FMF) is linked to amyloidosis. This finding highlights a significant genotype-phenotype correlation in pediatric FMF patients.

Area of Science:

  • Genetics
  • Rheumatology
  • Pediatrics

Background:

  • Familial Mediterranean fever (FMF) is a genetic autoinflammatory disorder.
  • Childhood-onset FMF presents unique clinical and demographic characteristics.
  • Understanding genotype-phenotype correlations is crucial for managing FMF.

Purpose of the Study:

  • To review clinical and demographic features of pediatric FMF patients.
  • To investigate the phenotype-genotype correlation in child-onset FMF.
  • To assess the association between specific mutations and disease manifestations.

Main Methods:

  • Retrospective review of 102 pediatric FMF patients' medical records.
  • Classification of patients into three genotype groups based on M694V and other mutations.
  • Comparison of clinical features, including amyloidosis, across genotype groups.

Main Results:

  • Homozygosity for the Met694Val (M694V) mutation was identified in 45% of patients.
  • M694V homozygosity was significantly associated with the development of amyloidosis.
  • This suggests a strong link between this specific genotype and a severe FMF phenotype.

Conclusions:

  • M694V homozygosity is associated with a distinct phenotype (Phenotype II) and increased risk of amyloidosis in FMF patients.
  • Further large-scale prospective studies are needed to fully elucidate FMF in diverse ethnic groups.
  • Genotype information can aid in predicting disease severity and guiding treatment strategies.

More Related Videos

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

Related Concept Videos

Pedigree Analysis01:35

Pedigree Analysis

Overview
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Background and Environment Affect Phenotype02:27

Background and Environment Affect Phenotype

Although the genetic makeup of an organism plays a major role in determining the phenotype, there are also several environmental factors, such as temperature, oxygen availability, presence of mutagens, that can alter an organism’s phenotype.
An example of how genetic background affects phenotype can be seen in horses. The Extension gene in horses is responsible for their coat color. A wild-type gene (EE) produces black pigment in the coat, while a mutant gene (ee) produces red pigment. A...
Genetic Lingo01:11

Genetic Lingo

Overview
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...